天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2014年
9期
903-907,908
,共6页
李杨%秦勤%任蓓%赵丽丽%毛用敏%郑萍
李楊%秦勤%任蓓%趙麗麗%毛用敏%鄭萍
리양%진근%임배%조려려%모용민%정평
脂联素%多态性,单核苷酸%高血压%冠心病%Logistic模型
脂聯素%多態性,單覈苷痠%高血壓%冠心病%Logistic模型
지련소%다태성,단핵감산%고혈압%관심병%Logistic모형
adiponectin%polymorphism,single nucleotide%hypertension%coronary disease%Logistic models
目的:探讨原发性高血压患者血清脂联素水平及其基因单核苷酸多态性(SNP)rs266729、rs7649121、rs1501299、rs3774262与冠心病及冠脉病变程度的关系。方法以高血压患者414例(其中单纯高血压患者180例,高血压合并冠心病患者234例)和正常对照组185例为研究对象,应用酶联免疫吸附法(ELISA)测定血清脂联素水平,聚合酶链反应-限制性片段长度多态性(PCR-RFLP)法检测脂联素rs266729、rs7649121、rs1501299、rs3774262位点多态性。结果高血压合并冠心病组脂联素水平较对照组和单纯高血压组显著降低。脂联素rs7649121位点杂合子AT基因型较AA基因型可降低冠心病风险(校正OR=0.566,95%CI 0.346~0.925,P=0.023)。多元Logistic回归分析显示年龄、LDL-C为冠心病的危险因素,脂联素为冠心病的保护因素。随着病变支数增加,脂联素水平呈逐渐降低趋势。脂联素SNP位点基因型对血清脂联素水平无明显影响。结论脂联素水平降低是高血压患者发生冠心病的独立危险因素,且随着冠脉病变程度的加重,脂联素水平逐渐降低。脂联素rs7649121位点多态性可能与高血压患者并发冠心病有关。
目的:探討原髮性高血壓患者血清脂聯素水平及其基因單覈苷痠多態性(SNP)rs266729、rs7649121、rs1501299、rs3774262與冠心病及冠脈病變程度的關繫。方法以高血壓患者414例(其中單純高血壓患者180例,高血壓閤併冠心病患者234例)和正常對照組185例為研究對象,應用酶聯免疫吸附法(ELISA)測定血清脂聯素水平,聚閤酶鏈反應-限製性片段長度多態性(PCR-RFLP)法檢測脂聯素rs266729、rs7649121、rs1501299、rs3774262位點多態性。結果高血壓閤併冠心病組脂聯素水平較對照組和單純高血壓組顯著降低。脂聯素rs7649121位點雜閤子AT基因型較AA基因型可降低冠心病風險(校正OR=0.566,95%CI 0.346~0.925,P=0.023)。多元Logistic迴歸分析顯示年齡、LDL-C為冠心病的危險因素,脂聯素為冠心病的保護因素。隨著病變支數增加,脂聯素水平呈逐漸降低趨勢。脂聯素SNP位點基因型對血清脂聯素水平無明顯影響。結論脂聯素水平降低是高血壓患者髮生冠心病的獨立危險因素,且隨著冠脈病變程度的加重,脂聯素水平逐漸降低。脂聯素rs7649121位點多態性可能與高血壓患者併髮冠心病有關。
목적:탐토원발성고혈압환자혈청지련소수평급기기인단핵감산다태성(SNP)rs266729、rs7649121、rs1501299、rs3774262여관심병급관맥병변정도적관계。방법이고혈압환자414례(기중단순고혈압환자180례,고혈압합병관심병환자234례)화정상대조조185례위연구대상,응용매련면역흡부법(ELISA)측정혈청지련소수평,취합매련반응-한제성편단장도다태성(PCR-RFLP)법검측지련소rs266729、rs7649121、rs1501299、rs3774262위점다태성。결과고혈압합병관심병조지련소수평교대조조화단순고혈압조현저강저。지련소rs7649121위점잡합자AT기인형교AA기인형가강저관심병풍험(교정OR=0.566,95%CI 0.346~0.925,P=0.023)。다원Logistic회귀분석현시년령、LDL-C위관심병적위험인소,지련소위관심병적보호인소。수착병변지수증가,지련소수평정축점강저추세。지련소SNP위점기인형대혈청지련소수평무명현영향。결론지련소수평강저시고혈압환자발생관심병적독립위험인소,차수착관맥병변정도적가중,지련소수평축점강저。지련소rs7649121위점다태성가능여고혈압환자병발관심병유관。
Objective To observe the association between adiponectin gene polymorphism, serum adiponectin lev-els with the incidence of coronary artery disease (CAD) and the severity of coronary artery stenosis in patients with essential hypertension (EH). Methods A total of 414 patients with EH (234 cases with CAD and 180 cases without CAD) and 185 control subjects were recruited in this study. Serum adiponectin levels were measured by enzyme-linked immunosorbent as-say (ELISA). Adiponectin single-nucleotide polymorphisms rs266729,rs7649121,rs1501299 and rs3774262 were geno-typed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results Serum adiponectin levels were significantly lower in EH with CAD group than those in control group and EH without CAD group. Adiponectin SNP rs7649121 AT genotype reduced the risk of CAD compared with AA genotype (adjusted OR=0.566,95%CI 0.346-0.925,P=0.023). Logistic regression analysis showed that age and LDL-C were risk factors of CAD, and adiponectin was the protective factor for CAD in EH patients. The severity of coronary artery stenosis was negatively related to the level of adipo-nectin. Adiponectin levels were not affected by the adiponectin gene polymorphism. Conclusion The decreased serum adi-ponectin level was the independent risk factor for CAD in EH patients, which was negatively related to the severity of coro-nary artery stenosis. Adiponectin SNP rs7649121 may contribute to the risk factors of CAD in EH patients.